Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 4.804
Filter
1.
Head Face Med ; 20(1): 38, 2024 Jul 12.
Article in English | MEDLINE | ID: mdl-38997761

ABSTRACT

BACKGROUND: A parotid abscess (PA) is a complication of an acute bacterial parotitis with a potentially life-threatening course. To date, data on the diagnosis and therapy of PA is sparse and mostly consists of case reports or case series. Therefore, this study aimed at comprehensively analyzing the microbiological spectrum and the therapeutic management in a bi-institutional setting. METHODS: A retrospective clinical chart review was performed to identify all patients surgically treated for PA at two tertiary care centers in Germany. Data on demographics, clinical management and microbiological data including species identification, pathogenicity, type of antibiotic therapy, adjustment of antibiotics, antibiotic sensitivity testing, and smear test results were extracted. Intervention-related variables and etiology were analyzed for their statistical association with outcome variables. RESULTS: Overall, 85 patients were included. Most patients (92.9%) underwent surgical incision. Around half of the patients (45.9%) were treated under local anesthesia. No facial nerve palsy was observed. The most frequently detected pathogens were Streptococci (n = 23), followed by Staphylococcus aureus (n = 6) including one case of methicillin-resistant Staphylococcus aureus. Most patients (68.2%) received an aminopenicillin ± beta-lactamase inhibitor as empiric antibiotic therapy. In 6 cases the antibiotic therapy was modified after receiving the antibiogram. Four patients (5.2%) presented with recurrent PA. Etiology was idiopathic (42.4%), followed by tumorous (12.9%), obstructive, and immunosuppressive (each 11.8%). Patients with a dental focus (p = 0.007) had a longer duration of hospitalization. CONCLUSION: The results show that the surgical therapy of PA under local anesthesia is safe. A dental examination should routinely be performed to rule out a dental focus. Obtaining a microbiological specimen in order to modify antibiotic therapy if necessary and a histopathological specimen to rule out a tumorous etiology is obligate.


Subject(s)
Abscess , Anti-Bacterial Agents , Humans , Male , Retrospective Studies , Female , Abscess/microbiology , Abscess/therapy , Abscess/surgery , Abscess/drug therapy , Middle Aged , Anti-Bacterial Agents/therapeutic use , Adult , Aged , Germany , Parotitis/microbiology , Parotitis/drug therapy , Parotitis/surgery , Parotitis/therapy , Parotid Diseases/microbiology , Parotid Diseases/surgery , Parotid Diseases/drug therapy , Microbial Sensitivity Tests , Young Adult , Aged, 80 and over , Treatment Outcome , Adolescent
3.
BMC Infect Dis ; 24(1): 697, 2024 Jul 14.
Article in English | MEDLINE | ID: mdl-39004725

ABSTRACT

BACKGROUND: This case report presents a unique instance of abscesses with an uncommon pathogen isolated from blood cultures. CASE PRESENTATION: We present the case of a perianal abscess in a 50-year-old man with a history of cocaine abuse and bilateral hip replacements. The rapid progression led to septic shock and multi-organ failure, requiring intensive care unit admission, surgery including protective transversostomy. Blood cultures showed growth of Butyricimonas spp. with resistance to penicillin and piperacillin-tazobactam. The immediate switch to meropenem led to a significant improvement in the patient's condition. The patient was discharged after 40 days of hospitalization in good general condition and the reversal of the transversostomy was performed six months later. CONCLUSION: The identification of Butyricimonas faecihominis, a rarely reported pathogen, emphasizes the challenges of diagnosing and treating unusual infections. This case emphasizes the importance of rapid microbiological diagnosis, interdisciplinary collaboration, and targeted antibiotic therapy in the treatment of abscesses and sepsis.


Subject(s)
Abscess , Anti-Bacterial Agents , Humans , Male , Middle Aged , Abscess/microbiology , Abscess/drug therapy , Anti-Bacterial Agents/therapeutic use , Anti-Bacterial Agents/pharmacology , Meropenem/therapeutic use
4.
J Med Case Rep ; 18(1): 300, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38946001

ABSTRACT

BACKGROUND: Necrotizing myopathies and muscle necrosis can be caused by immune-mediated mechanisms, drugs, ischemia, and infections, and differential diagnosis may be challenging. CASE PRESENTATION: We describe a case of diabetic myonecrosis complicated by pyomyositis and abscess caused by Escherichia coli. A white woman in her late forties was admitted to the hospital with a 1.5 week history of bilateral swelling, weakness, and mild pain of the lower extremities and inability to walk. She had a history of type 1 diabetes complicated by diabetic retinopathy, neuropathy, nephropathy, and end-stage renal disease. C-reactive protein was 203 mg/l, while creatinine kinase was only mildly elevated to 700 IU/l. Magnetic resonance imaging of her lower limb muscles showed extensive edema, and muscle biopsy was suggestive of necrotizing myopathy with mild inflammation. No myositis-associated or myositis-specific antibodies were detected. Initially, she was suspected to have seronegative immune-mediated necrotizing myopathy, but later her condition was considered to be explained better by diabetic myonecrosis with multifocal involvement. Her symptoms alleviated without any immunosuppressive treatment. After a month, she developed new-onset and more severe symptoms in her right posterior thigh. She was diagnosed with emphysematous urinary tract infection and emphysematous myositis and abscess of the right hamstring muscle. Bacterial cultures of drained pus from abscess and urine were positive for Escherichia coli. In addition to abscess drainage, she received two 3-4-week courses of intravenous antibiotics. In the discussion, we compare the symptoms and findings typically found in pyomyositis, immune-mediated necrotizing myopathy, and diabetic myonecrosis (spontaneous ischemic necrosis of skeletal muscle among people with diabetes). All of these diseases may cause muscle weakness and pain, muscle edema in imaging, and muscle necrosis. However, many differences exist in their clinical presentation, imaging, histology, and extramuscular symptoms, which can be useful in determining diagnosis. As pyomyositis often occurs in muscles with pre-existing pathologies, the ischemic muscle has likely served as a favorable breeding ground for the E. coli in our case. CONCLUSIONS: Identifying the etiology of necrotizing myopathy is a diagnostic challenge and often requires a multidisciplinary assessment of internists, pathologists, and radiologists. Moreover, the presence of two rare conditions concomitantly is possible in cases with atypical features.


Subject(s)
Abscess , Anti-Bacterial Agents , Escherichia coli Infections , Magnetic Resonance Imaging , Necrosis , Pyomyositis , Female , Humans , Abscess/complications , Abscess/microbiology , Anti-Bacterial Agents/therapeutic use , Diabetes Mellitus, Type 1/complications , Escherichia coli/isolation & purification , Escherichia coli Infections/complications , Escherichia coli Infections/diagnosis , Pyomyositis/diagnosis , Pyomyositis/complications , Pyomyositis/microbiology , Urinary Tract Infections/complications , Urinary Tract Infections/diagnosis , Adult
5.
Clin Lab ; 70(6)2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38868873

ABSTRACT

BACKGROUND: From June 2021 to July 2021, our hospital confirmed 3 cases of Mycobacterium infection in skin abscesses. All 3 patients underwent thread embedding and weight loss surgery at the same informal beauty institution, with a history of silk protein injection. None of the patients had any other underlying diseases or surgical history. Symptoms and signs show that the disease is acute and the course of the disease is short. All patients have found subcutaneous masses in different parts of the body. In most cases, the masses show redness and swelling, and some of the masses are accompanied by tenderness, wave sensation, and rupture. After some of the masses rupture, purulent secretions can be seen. METHODS: The pus secreted by the skin lesions of the three patients were cultured to a single bacterium, which was identified by MALDI-TOF MS. Multiple locus sequence typing (MLST) was performed using three specific genes (hsp65, rpoB, and secA1) and seven housekeeping genes (argH, cya, glpK, gnd, murC, pta, and purH). The results were queried through the MLST database of Mycobacterium abscess. RESULTS: All three strains of bacteria were Mycobacterium abscess type ST279 massiliense subtype. Three antibacterial drugs including cefmetazole, amikacin, and clarithromycin were administered in combination with 5-aminolevulinic acid photodynamic therapy (ALA-PDT). After 3 - 6 months, there was no obvious redness or swelling in the surrounding tissues of the wound, and no obvious purulent secretions were observed. All patients were cured and discharged from the hospital. After a follow-up of six months, there was no recurrence of the lesions. CONCLUSIONS: Medical institutions must strictly follow infection control guidelines and take preventive measures to prevent such incidents from happening again. ALA-PDT as a combination therapy for nontuberculous Mycobacterium (NTM) skin infections can improve treatment efficacy and shorten antibiotic usage time.


Subject(s)
Anti-Bacterial Agents , Disease Outbreaks , Mycobacterium Infections, Nontuberculous , Humans , Female , Mycobacterium Infections, Nontuberculous/epidemiology , Mycobacterium Infections, Nontuberculous/diagnosis , Mycobacterium Infections, Nontuberculous/microbiology , Adult , Anti-Bacterial Agents/therapeutic use , Skin Diseases, Bacterial/epidemiology , Skin Diseases, Bacterial/microbiology , Skin Diseases, Bacterial/diagnosis , Skin Diseases, Bacterial/drug therapy , Male , Middle Aged , Abscess/microbiology , Abscess/epidemiology , Abscess/diagnosis , Mycobacterium abscessus/isolation & purification , Mycobacterium abscessus/genetics , Nontuberculous Mycobacteria/isolation & purification , Nontuberculous Mycobacteria/genetics , Nontuberculous Mycobacteria/drug effects
6.
BMJ Case Rep ; 17(6)2024 Jun 18.
Article in English | MEDLINE | ID: mdl-38890117

ABSTRACT

Actinomycosis is a rare endogenous infection characterised by indolent progression, contiguous spreading, abscess formation and draining sinuses. Here, we present a case of Schaalia odontolytica causing a mediastinal abscess that is unique in its acuity and location. Our patient presented with worsening dysphagia, and CT of her chest revealed a new mass in the posterior mediastinum displacing the oesophagus. Oesophagram revealed mild motility disorder, but no masses or ulcers within the oesophagus. Oesophagogastroduodenoscopy with endoscopic ultrasound revealed extrinsic compression of the oesophagus. Fine-needle aspiration of the mass yielded purulent fluid, which was cultured. A single colony of S. odontolytica was isolated. Initially, medical treatment was favoured, but as she developed worsening dysphagia, the abscess was drained. She continued on long-term antibiotic therapy after drainage and had complete resolution of the abscess at 1 year.


Subject(s)
Actinomycosis , Deglutition Disorders , Immunocompromised Host , Mediastinal Diseases , Humans , Female , Actinomycosis/diagnosis , Actinomycosis/complications , Actinomycosis/drug therapy , Deglutition Disorders/etiology , Mediastinal Diseases/diagnosis , Diagnosis, Differential , Abscess/diagnosis , Abscess/microbiology , Anti-Bacterial Agents/therapeutic use , Tomography, X-Ray Computed , Drainage , Middle Aged , Mediastinum
8.
FP Essent ; 541: 14-19, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38896826

ABSTRACT

Bacterial skin infections represent a significant health care burden. Cellulitis and erysipelas are rapidly spreading, painful, superficial skin infections, usually caused by streptococci or Staphylococcus aureus. Folliculitis is an infection of hair follicles mostly caused by S aureus. Simple folliculitis typically is self-limited. Topical benzoyl peroxide is a first-line nonantibiotic treatment. Mupirocin and clindamycin are topical antibiotic options. For treatment-resistant cases, oral cephalexin or dicloxacillin is an appropriate option. Impetigo is a common, self-limited infection in children. Bullous impetigo is caused by S aureus, and nonbullous impetigo is caused by beta-hemolytic streptococci, S aureus, or both. In most cases, topical mupirocin or retapamulin (Altabax) is effective. Oral antibiotics should be considered for household outbreaks or patients with multiple lesions. Abscesses are red, painful collections of purulence in the dermis and deeper tissues caused by S aureus or polymicrobial infections. Furuncles are abscesses of a hair follicle, whereas carbuncles involve several hair follicles. In recurrent cases of these lesions, culture of the exudate is recommended. Abscess, furuncle, and carbuncle management consists of incision and drainage. Oral antibiotics are not necessary in most cases but should be prescribed for patients with severe immunocompromise or systemic signs of infection. In bacterial skin infections, methicillin-resistant S aureus coverage should be considered for patients with infections that have not improved with treatment.


Subject(s)
Anti-Bacterial Agents , Cellulitis , Impetigo , Skin Diseases, Bacterial , Humans , Child , Anti-Bacterial Agents/therapeutic use , Adolescent , Impetigo/diagnosis , Impetigo/drug therapy , Skin Diseases, Bacterial/diagnosis , Skin Diseases, Bacterial/drug therapy , Skin Diseases, Bacterial/microbiology , Skin Diseases, Bacterial/therapy , Cellulitis/diagnosis , Cellulitis/drug therapy , Cellulitis/microbiology , Cellulitis/therapy , Folliculitis/diagnosis , Folliculitis/drug therapy , Folliculitis/microbiology , Erysipelas/diagnosis , Erysipelas/drug therapy , Abscess/diagnosis , Abscess/therapy , Abscess/microbiology , Furunculosis/diagnosis , Furunculosis/drug therapy , Furunculosis/therapy , Furunculosis/microbiology , Carbuncle/diagnosis , Carbuncle/therapy
9.
BMC Infect Dis ; 24(1): 601, 2024 Jun 19.
Article in English | MEDLINE | ID: mdl-38898385

ABSTRACT

BACKGROUND: Cutibacterium acnes is an anaerobic bacterium mostly implicated in cutaneous and body-implant infections. Splenic abscess is a rare entity and C. acnes abscesses have only exceptionally been reported. We describe a spontaneous splenic C. acnes abscess in an immunocompetent man with no predisposing factors or identified portal of entry. His isolates were subjected to single-locus sequence typing (SLST) to explore their genetic relatedness and better understand this rare infection. CASE PRESENTATION: A splenic abscess was diagnosed on a computed-tomography scan in a 74-year-old man with chronic abdominal pain. No risk factor was identified. Abscess-drained pus and post-drainage blood cultures grew C. acnes. SLST of abscess and blood isolates showed that they belonged to the same C. acnes SLST type C1 found in normal skin and rarely in inflammatory skin disease. Specific virulence factors could not be identified. CONCLUSION: C. acnes abscesses are extremely rare and can develop in immunocompetent patients without an identifiable portal of entry. Molecular typing of clinical isolates can help confirm infection (versus contamination) and enables genetic background comparisons. Further research is needed to understand C. acnes tropism and virulence.


Subject(s)
Bacteremia , Gram-Positive Bacterial Infections , Splenic Diseases , Humans , Male , Aged , Bacteremia/microbiology , Splenic Diseases/microbiology , Gram-Positive Bacterial Infections/microbiology , Gram-Positive Bacterial Infections/diagnosis , Abscess/microbiology , Phylogeny , Immunocompetence , Tomography, X-Ray Computed
10.
Sci Rep ; 14(1): 11848, 2024 05 24.
Article in English | MEDLINE | ID: mdl-38782931

ABSTRACT

Despite extensive characterisation of uropathogenic Escherichia coli (UPEC) causing urinary tract infections (UTIs), the genetic background of non-urinary extraintestinal pathogenic E. coli (ExPEC) in companion animals remains inadequately understood. In this study, we characterised virulence traits of 104 E. coli isolated from canine pyometra (n = 61) and prostatic abscesses (PAs) (n = 38), and bloodstream infections (BSIs) in dogs (n = 2), and cats (n = 3). A stronger association with UPEC of pyometra strains in comparison to PA strains was revealed. Notably, 44 isolates exhibited resistance to third-generation cephalosporins and/or fluoroquinolones, 15 were extended-spectrum ß-lactamase-producers. Twelve multidrug-resistant (MDR) strains, isolated from pyometra (n = 4), PAs (n = 5), and BSIs (n = 3), along with 7 previously characterised UPEC strains from dogs and cats, were sequenced. Genomic characteristics revealed that MDR E. coli associated with UTIs, pyometra, and BSIs belonged to international high-risk E. coli clones, including sequence type (ST) 38, ST131, ST617, ST648, and ST1193. However, PA strains belonged to distinct lineages, including ST12, ST44, ST457, ST744, and ST13037. The coreSNPs, cgMLST, and pan-genome illustrated intra-clonal variations within the same ST from different sources. The high-risk ST131 and ST1193 (phylogroup B2) contained high numbers of ExPEC virulence genes on pathogenicity islands, predominating in pyometra and UTI. Hybrid MDR/virulence IncF multi-replicon plasmids, containing aerobactin genes, were commonly found in non-B2 phylogroups from all sources. These findings offer genomic insights into non-urinary ExPEC, highlighting its potential for invasive infections in pets beyond UTIs, particularly with regards to high-risk global clones.


Subject(s)
Abscess , Dog Diseases , Drug Resistance, Multiple, Bacterial , Escherichia coli Infections , Pyometra , Urinary Tract Infections , Dogs , Animals , Urinary Tract Infections/microbiology , Urinary Tract Infections/veterinary , Drug Resistance, Multiple, Bacterial/genetics , Male , Dog Diseases/microbiology , Cats , Escherichia coli Infections/microbiology , Escherichia coli Infections/veterinary , Pyometra/microbiology , Pyometra/veterinary , Pyometra/genetics , Abscess/microbiology , Abscess/veterinary , Female , Cat Diseases/microbiology , Uropathogenic Escherichia coli/genetics , Uropathogenic Escherichia coli/drug effects , Uropathogenic Escherichia coli/pathogenicity , Escherichia coli/genetics , Escherichia coli/pathogenicity , Escherichia coli/drug effects , Anti-Bacterial Agents/pharmacology , Prostatic Diseases/microbiology , Prostatic Diseases/veterinary , Prostatic Diseases/genetics , Virulence/genetics , Virulence Factors/genetics
12.
J Antimicrob Chemother ; 79(7): 1668-1672, 2024 Jul 01.
Article in English | MEDLINE | ID: mdl-38785349

ABSTRACT

BACKGROUND: Invasive fungal infections (IFIs) are severe and difficult-to-treat infections affecting immunocompromised patients. Antifungal drug penetration at the site of infection is critical for outcome and may be difficult to achieve. Data about antifungal drug distribution in infected human tissues under real circumstances of IFI are scarce. METHODS: Multiple samples were obtained from soft tissue abscesses of a lung transplant patient with Candida albicans invasive candidiasis who underwent recurrent procedures of drainage, while receiving different consecutive courses of antifungal therapy [itraconazole (ITC), fluconazole, caspofungin]. Antifungal drug concentrations were measured simultaneously at the site of infection (surrounding inflammatory tissue and fluid content of the abscess) and in plasma for calculation of the tissue/plasma ratio (R). The concentration within the infected tissue was interpreted as appropriate if it was equal or superior to the MIC of the causal pathogen. RESULTS: A total of 30 tissue samples were collected for measurements of ITC (n = 12), fluconazole (n = 17) and caspofungin (n = 1). Variable concentrations were observed in the surrounding tissue of the lesions with median R of 2.79 (range 0.51-15.9) for ITC and 0.94 (0.21-1.37) for fluconazole. Concentrations ranges within the fluid content of the abscesses were 0.39-1.83 for ITC, 0.66-1.02 for fluconazole and 0.23 (single value) for caspofungin. The pharmacodynamic target (tissue concentration ≥ MIC) was achieved in all samples for all three antifungal drugs. CONCLUSIONS: This unique dataset of antifungal drug penetration in infected human soft tissue abscesses suggests that ITC, fluconazole and caspofungin could achieve appropriate concentrations in soft tissue abscesses.


Subject(s)
Abscess , Antifungal Agents , Caspofungin , Soft Tissue Infections , Humans , Antifungal Agents/pharmacokinetics , Antifungal Agents/therapeutic use , Antifungal Agents/administration & dosage , Abscess/drug therapy , Abscess/microbiology , Caspofungin/pharmacokinetics , Caspofungin/therapeutic use , Soft Tissue Infections/drug therapy , Soft Tissue Infections/microbiology , Fluconazole/pharmacokinetics , Fluconazole/therapeutic use , Fluconazole/administration & dosage , Candida albicans/drug effects , Candidiasis, Invasive/drug therapy , Candidiasis, Invasive/microbiology , Microbial Sensitivity Tests , Male , Itraconazole/pharmacokinetics , Itraconazole/therapeutic use , Itraconazole/administration & dosage , Middle Aged , Female , Adult
14.
Hand Surg Rehabil ; 43(3): 101722, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38788799

ABSTRACT

CASE: A 41-year-old male presented with an insidious onset of pain and swelling about the dorsal wrist, and was found to have a Brodie's abscess in the distal radius. The patient had a history of a distal radius fracture, treated with external fixation, nineteen years prior, which we believe contributed to the infection. The patient was treated surgically with abscess irrigation, debridement, bony curettage, bioactive glass S53P4 allograft, with concurrent antibiotic therapy. CONCLUSION: Brodie's abscesses can have atypical presentations, and a thorough history must be obtained from patients to identify any potential sources of infection.


Subject(s)
Abscess , Radius Fractures , Humans , Male , Adult , Radius Fractures/surgery , Abscess/etiology , Abscess/surgery , Abscess/microbiology , Debridement , Fracture Fixation/adverse effects , External Fixators , Anti-Bacterial Agents/therapeutic use , Osteomyelitis/etiology , Osteomyelitis/surgery
16.
BMJ Case Rep ; 17(5)2024 May 22.
Article in English | MEDLINE | ID: mdl-38782428

ABSTRACT

A late middle-aged woman presented with a large, painful neck mass, with a history of rapid increase of size since 1 week and associated voice change, dyspnoea and odynophagia. Prior radiological investigation showed a multiloculated cystic mass in the left thyroid lobe. Fine needle aspiration revealed a predominant cluster of neutrophils. Blood investigations showed leucocytosis and high blood glucose levels suggestive of sepsis. The patient underwent surgical drainage of the thyroid abscess with total thyroidectomy which was managed through multidisciplinary teamwork between surgeons, haematologists, endocrinologists and anaesthesiologists. In addition, urine culture and thyroid pus culture both showed Escherichia coli growth suggestive of bacterial sepsis. The patient was treated successfully and made a complete recovery following surgery with normalisation of voice.


Subject(s)
Drainage , Sepsis , Thyroid Diseases , Thyroidectomy , Humans , Female , Sepsis/complications , Sepsis/microbiology , Drainage/methods , Middle Aged , Thyroid Diseases/complications , Thyroid Diseases/diagnosis , Thyroid Diseases/microbiology , Thyroid Diseases/surgery , Abscess/microbiology , Abscess/diagnosis , Abscess/complications , Escherichia coli Infections/complications , Escherichia coli Infections/diagnosis , Escherichia coli Infections/therapy , Thyroid Gland/pathology , Thyroid Gland/diagnostic imaging , Anti-Bacterial Agents/therapeutic use
17.
Article in English | MEDLINE | ID: mdl-38765535

ABSTRACT

Objective: The aim of this study is to evaluate the etiological profile and antimicrobial resistance in breast abscess cultures from patients from the community, treated at a public hospital located in Porto Alegre, Brazil. Methods: This is an retrospective cross-sectional study that evaluated the medical records of patients with bacterial isolates in breast abscess secretion cultures and their antibiograms, from January 2010 to August 2022. Results: Based on 129 positive cultures from women from the community diagnosed with breast abscesses and treated at Fêmina Hospital, 99 (76.7%) of the patients had positive cultures for Staphylococcus sp, 91 (92%) of which were cases of Staphylococcus aureus. Regarding the resistance profile of S. aureus, 32% of the strains were resistant to clindamycin, 26% to oxacillin and 5% to trimethoprim-sulfamethoxazole. The antimicrobials vancomycin, linezolid and tigecycline did not show resistance for S. aureus. Conclusion: Staphylococcus aureus was the most common pathogen found in the breast abscess isolates during the study period. Oxacillin remains a good option for hospitalized patients. The use of sulfamethoxazole plus trimethoprim should be considered as a good option for use at home, due to its low bacterial resistance, effectiveness and low cost.


Subject(s)
Abscess , Anti-Bacterial Agents , Humans , Female , Cross-Sectional Studies , Retrospective Studies , Abscess/microbiology , Adult , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Middle Aged , Staphylococcus aureus/drug effects , Staphylococcus aureus/isolation & purification , Brazil , Staphylococcal Infections/microbiology , Staphylococcal Infections/drug therapy , Microbial Sensitivity Tests , Drug Resistance, Bacterial , Breast Diseases/microbiology , Breast Diseases/drug therapy , Young Adult , Community-Acquired Infections/microbiology , Community-Acquired Infections/drug therapy , Adolescent
18.
Front Cell Infect Microbiol ; 14: 1352339, 2024.
Article in English | MEDLINE | ID: mdl-38808066

ABSTRACT

Antibiotic drug combination therapy is critical for the successful treatment of infections caused by multidrug resistant pathogens. We investigated the efficacy of ß-lactam and ß-lactam/ß-lactamase inhibitor combinations with other antibiotics, against the hypervirulent, ceftazidime/avibactam resistant Pseudomonas aeruginosa Liverpool epidemic strain (LES) B58. Although minimum inhibitory concentrations in vitro differed by up to eighty-fold between standard and host-mimicking media, combinatorial effects only marginally changed between conditions for some combinations. Effective combinations in vitro were further tested in a chronic, high-density murine infection model. Colistin and azithromycin demonstrated combinatorial effects with ceftazidime and ceftazidime/avibactam both in vitro and in vivo. Conversely, while tobramycin and tigecycline exhibited strong synergy in vitro, this effect was not observed in vivo. Our approach of using host-mimicking conditions and a sophisticated animal model to evaluate drug synergy against bacterial pathogens represents a promising approach. This methodology may offer insights into the prediction of combination therapy outcomes and the identification of potential treatment failures.


Subject(s)
Abscess , Anti-Bacterial Agents , Disease Models, Animal , Drug Synergism , Drug Therapy, Combination , Microbial Sensitivity Tests , Pseudomonas Infections , Pseudomonas aeruginosa , Animals , Pseudomonas aeruginosa/drug effects , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Pseudomonas Infections/drug therapy , Pseudomonas Infections/microbiology , Mice , Abscess/drug therapy , Abscess/microbiology , Drug Combinations , Drug Resistance, Multiple, Bacterial , Female , Ceftazidime/pharmacology , Ceftazidime/therapeutic use , Azithromycin/pharmacology , Azithromycin/therapeutic use , Azithromycin/administration & dosage , Azabicyclo Compounds/pharmacology , Azabicyclo Compounds/therapeutic use , Colistin/pharmacology , Colistin/therapeutic use , Colistin/administration & dosage
20.
Transpl Infect Dis ; 26(3): e14278, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38584595

ABSTRACT

A renal allograft abscess is a relatively rare condition. Appropriate antimicrobial therapy and drainage are recommended for treating renal abscesses. However, drainage can be challenging, depending on the location of the abscess. We present the case of a young female kidney transplant recipient who was successfully cured of a renal allograft abscess, using antimicrobial agents and appropriate follow-up imaging, without the need of any risky procedures.


Subject(s)
Abscess , Allografts , Kidney Transplantation , Humans , Kidney Transplantation/adverse effects , Female , Abscess/drug therapy , Abscess/microbiology , Abscess/diagnostic imaging , Abscess/surgery , Adult , Anti-Bacterial Agents/therapeutic use , Drainage , Treatment Outcome , Anti-Infective Agents/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL